Stockreport

PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights [Yahoo! Finance]

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF PMV Pharmaceuticals, Inc. Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refracto [Read more]